Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19356
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPereira-Salgado, Amanda-
dc.contributor.authorWestwood, Jennifer A-
dc.contributor.authorRussell, Lahiru-
dc.contributor.authorUgalde, Anna-
dc.contributor.authorOrtlepp, Bronwen-
dc.contributor.authorSeymour, John F-
dc.contributor.authorButow, Phyllis-
dc.contributor.authorCavedon, Lawrence-
dc.contributor.authorOng, Kevin-
dc.contributor.authorAranda, Sanchia-
dc.contributor.authorBreen, Sibilah-
dc.contributor.authorKirsa, Suzanne-
dc.contributor.authorDunlevie, Andrew-
dc.contributor.authorSchofield, Penelope-
dc.date2017-
dc.date.accessioned2018-09-16T23:53:58Z-
dc.date.available2018-09-16T23:53:58Z-
dc.date.issued2017-12-06-
dc.identifier.citationJMIR mHealth and uHealth 2017; 5(12): e184-
dc.identifier.issn2291-5222-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/19356-
dc.description.abstractOptimal dosing of oral tyrosine kinase inhibitor therapy is critical to treatment success and survival of patients with chronic myeloid leukemia (CML). Drug intolerance secondary to toxicities and nonadherence are significant factors in treatment failure. The objective of this study was to develop and pilot-test the clinical feasibility and acceptability of a mobile health system (REMIND) to increase oral drug adherence and patient symptom self-management among people with CML (chronic phase). A multifaceted intervention was iteratively developed using the intervention development framework by Schofield and Chambers, consisting of defining the patient problem and iteratively refining the intervention. The clinical feasibility and acceptability were examined via patient and intervention nurse interviews, which were audiotaped, transcribed, and deductively content analyzed. The intervention comprised 2 synergistically operating elements: (1) daily medication reminders and routine assessment of side effects with evidence-based self-care advice delivered in real time and (2) question prompt list (QPL) questions and routinely collected individual patient adherence and side effect profile data used to shape nurses' consultations, which employed motivational interviewing to support adoption of self-management behaviors. A total of 4 consultations and daily alerts and advice were delivered over 10 weeks. In total, 58% (10/17) of patients and 2 nurses participated in the pilot study. Patients reported several benefits of the intervention: help in establishing medication routines, resolution of symptom uncertainty, increased awareness of self-care, and informed decision making. Nurses also endorsed the intervention: it assisted in establishing pill-taking routines and patients developing effective solutions to adherence challenges. The REMIND system with nurse support was usable and acceptable to both patients and nurses. It has the potential to improve adherence and side-effect management and should be further evaluated.-
dc.language.isoeng-
dc.subjectInternet-
dc.subjectmedication adherence-
dc.subjectmobile phone-
dc.subjectneoplasms-
dc.titleMobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment.-
dc.typeJournal Article-
dc.identifier.journaltitleJMIR mHealth and uHealth-
dc.identifier.affiliationCentre for Nursing Research, Cabrini Institute, Malvern, Victoria, Australia-
dc.identifier.affiliationFaculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia-
dc.identifier.affiliationDepartment of Cancer Experiences Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia-
dc.identifier.affiliationSchool of Nursing and Midwifery, Faculty of Health, Deakin University, Geelong, Victoria, Australia-
dc.identifier.affiliationDepartment of Haematology, Royal Adelaide Hospital, Adelaide, South Australia, Australia-
dc.identifier.affiliationDepartment of Haematology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia-
dc.identifier.affiliationSir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia-
dc.identifier.affiliationSchool of Psychology, The University of Sydney, Sydney, New South Wales, Australia-
dc.identifier.affiliationSchool of Science, RMIT University, Melbourne, Victoria, Australia-
dc.identifier.affiliationCancer Council Australia, Sydney, New South Wales, Australia-
dc.identifier.affiliationPublic Health Group, Stroke Division, The Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia-
dc.identifier.affiliationPharmacy Department, Monash Health, Clayton, Victoria, Australia-
dc.identifier.affiliationFaculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia-
dc.identifier.affiliationDepartment of Psychology, School of Health Sciences, Faculty of Health, Arts and Design, Swinburne University of Technology, Hawthorn, Victoria, Australia-
dc.identifier.doi10.2196/mhealth.8349-
dc.identifier.orcid0000-0002-8353-8230-
dc.identifier.orcid0000-0003-2957-5767-
dc.identifier.orcid0000-0002-3806-0020-
dc.identifier.orcid0000-0002-2473-8435-
dc.identifier.orcid0000-0002-2985-7791-
dc.identifier.orcid0000-0003-2188-6835-
dc.identifier.orcid0000-0003-3562-6954-
dc.identifier.orcid0000-0001-7464-857X-
dc.identifier.orcid0000-0003-0034-8368-
dc.identifier.orcid0000-0003-4170-9799-
dc.identifier.orcid0000-0001-9896-004X-
dc.identifier.orcid0000-0002-4029-3288-
dc.identifier.orcid0000-0002-1476-201X-
dc.identifier.orcid0000-0001-9495-9543-
dc.identifier.pubmedid29212628-
dc.type.austinJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

8
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.